van Houte Hans's Form 4 filing
Nurix Therapeutics, Inc. (NRIX) · filed Jul 30, 2025
- Accession no.
- 0001549595-25-000101
- Filed
- Jul 30, 2025
- Trade date
- Jul 30, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $51.7K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| van Houte HansCIK 0001817217 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2025 | Common Stock | MOption exerciseAcquired | +2,886 | $0.00 | $0 | 36,610 | Direct | |
| Jul 30, 2025 | Common Stock | MOption exerciseAcquired | +2,000 | $0.00 | $0 | 38,610 | Direct | |
| Jul 30, 2025 | Common Stock | MOption exerciseAcquired | +3,750 | $0.00 | $0 | 42,360 | Direct | |
| Jul 30, 2025 | Common Stock | MOption exerciseAcquired | +2,858 | $0.00 | $0 | 45,218 | Direct | |
| Jul 30, 2025 | Common Stock | SSaleDisposed | −4,304 | $12.01 | −$51,691.04 | 40,914 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2025 | Common Stock | MOption exerciseDisposed | −2,886 | $0.00 | $0 | 5,773 | Direct | |
| Jul 30, 2025 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 6,000 | Direct | |
| Jul 30, 2025 | Common Stock | MOption exerciseDisposed | −3,750 | $0.00 | $0 | 26,250 | Direct | |
| Jul 30, 2025 | Common Stock | MOption exerciseDisposed | −2,858 | $0.00 | $0 | 31,442 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.